Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV Severe Pneumonia”

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05085574
What this trial is testing

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

Who this might be right for
2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+9 more
Leidos Life Sciences
Not applicableStudy completedNCT04373759
What this trial is testing

Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs

Who this might be right for
Sars-CoV2Covid-19
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 186
Not applicableEnded earlyNCT04937608
What this trial is testing

Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters

Who this might be right for
Covid19Infertility, Male
Fertilys 2
Post-approval studies (Phase 4)Ended earlyNCT04351191
What this trial is testing

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds

Who this might be right for
Sars-CoV2Symptomatic ConditionCovid-19
Government of Punjab, Specialized Healthcare and Medical Education Department 137
Not applicableStudy completedNCT06735300
What this trial is testing

Saliva PCR in Pregnant Women with COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
National Cheng-Kung University Hospital 37
Testing effectiveness (Phase 2)Study completedNCT04649021
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population

Who this might be right for
SARS-CoV-2
BioNTech SE 960
Not applicableWithdrawnNCT06163677
What this trial is testing

Look at the Health Outcomes of Patients With COVID-19 and Influenza.

Who this might be right for
COVID-19Coronavirus Disease 2019Influenza
Pfizer
Testing effectiveness (Phase 2)Ended earlyNCT04391309
What this trial is testing

COVID-19 and Anti-CD14 Treatment Trial

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
National Institute of Allergy and Infectious Diseases (NIAID) 49
Not applicableStudy completedNCT05092698
What this trial is testing

The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19

Who this might be right for
SARS-CoV2 Infection
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 110
Testing effectiveness (Phase 2)Study completedNCT05438602
What this trial is testing

Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

Who this might be right for
COVID-19
Pfizer 158
Early research (Phase 1)Study completedNCT05263895
What this trial is testing

Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation

Who this might be right for
Bioavailability
Pfizer 12
Testing effectiveness (Phase 2)Study completedNCT04426695
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2,252
Not applicableEnded earlyNCT05252910
What this trial is testing

Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents

Who this might be right for
COVID-19
Pharm-Olam, LLC 33
Not applicableStudy completedNCT07089680
What this trial is testing

Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Pfizer 937
Early research (Phase 1)Study completedNCT04766931
What this trial is testing

The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection

Who this might be right for
Covid19
Frontier Biotechnologies Inc. 88
Not applicableEnded earlyNCT04569851
What this trial is testing

Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)

Who this might be right for
COVID-19 Infection
Savana Research 100,000
Large-scale testing (Phase 3)UnknownNCT05187793
What this trial is testing

Study of Efficacy of Different Treatment Regimens of Olokizumab

Who this might be right for
COVID-19
R-Pharm 198
Testing effectiveness (Phase 2)Study completedNCT04686773
What this trial is testing

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

Who this might be right for
COVID-19
R-Pharm 100
Testing effectiveness (Phase 2)Ended earlyNCT04472494
What this trial is testing

Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise

Who this might be right for
COVID-19SARS-CoV-2
Bristol-Myers Squibb 61
Not applicableStudy completedNCT04351503
What this trial is testing

A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19

Who this might be right for
SARS Coronavirus (SARS-CoV-2) Infection
University Hospital, Basel, Switzerland 126,586
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation